Most countries such as the United States and China are different from India ~
After all, the research and development cost of patented drugs is very high. Ignoring R&D interests and patent imitation will affect the follow-up research, which is tantamount to killing the goose that lays the golden egg.
Moreover, generic drugs are not controlled by patents and research and development, and the quality is difficult to control. Take the imitation of a health care product in India as an example, the effective components of the varieties that can be seen in the market are only a few hundred percent of those of patented drugs.